$2.03
-0.07-3.33%
Pre-Market: 6:20 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Innate Pharma in recent months.
Browse guidance and forecast on all stocks.